Pharma Traders Demand Higher Margins
  • Elizabeth George
  • Oct 10 2013

October 10: First there was a slowdown in sales when the new drug pricing mechanism got implemented in June 2013. Now pharma manufacturers are facing tough resistance from the traders’ community who are demanding higher margins. In many parts of the country, traders have not bought drugs since August, hitting the sales of the industry further. We tell you why traders are demanding a higher commission and evaluate its possible impact.